Oct 7 |
Update: Scholar Rock's Phase 3 Apitegromab Trial in Spinal Muscular Atrophy Meets Primary Endpoint
|
Oct 4 |
Applebee's Parent Dine Brands Falls After Truist Downgrade Tied to Sales Concerns
|
Oct 4 |
Rivian Cuts Full-Year Production Outlook Following Third-Quarter Miss Amid Supply Shortage
|
Oct 4 |
Rivian Automotive May Not Reach Positive Gross Margin This Year Over Component Shortage, Truist Says
|
Oct 3 |
Eli Lilly 'Got It Right' With Obesity Strategy as Capacity Expansion Continues, Truist Says
|
Oct 3 |
Tesla stock target raised at Truist on lower rates
|
Oct 2 |
Nike Turnaround Likely to Be Long, Uncertain Path, Truist Says
|
Oct 1 |
Restructuring Efforts, Lower Rates to Boost KEY Amid Asset Quality Woes
|
Sep 30 |
Truist announces third-quarter 2024 earnings call details
|
Sep 30 |
Truist Foundation increases Hurricane Helene relief, recovery support to $1 million
|